BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10617796)

  • 1. [Prognostic factors of survival without clinical recurrences in medullary thyroid carcinoma: apropos of 52 operated cases].
    Raffaitin P; Hamy A; Mirallie E; Meurette G; Duplessis R; Lemeunier P; Murat A; Le Bodic M; Le Neel JC; Paineau J; Visset J
    Ann Endocrinol (Paris); 1999 Dec; 60(6):435-42. PubMed ID: 10617796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of survival in medullary cancers of the thyroid. Apropos of 51 cases. Clinical, biochemical and immunocytochemical study].
    Goudet P; Rogissart F; Petit JM; Vaillant G; Durnerin I; Fraisse J; Justrabo E; Verges B; Cougard P
    Ann Chir; 1996; 50(1):23-9. PubMed ID: 8734273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
    Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
    J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
    Modigliani E; Cohen R; Campos JM; Conte-Devolx B; Maes B; Boneu A; Schlumberger M; Bigorgne JC; Dumontier P; Leclerc L; Corcuff B; Guilhem I
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):265-73. PubMed ID: 9578814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
    Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.
    Girelli ME; Nacamulli D; Pelizzo MR; De Vido D; Mian C; Piccolo M; Busnardo B
    Thyroid; 1998 Jun; 8(6):517-23. PubMed ID: 9669290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
    Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
    Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
    Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
    Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
    Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
    Elisei R; Bottici V; Luchetti F; Di Coscio G; Romei C; Grasso L; Miccoli P; Iacconi P; Basolo F; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):163-8. PubMed ID: 14715844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.
    Beressi N; Campos JM; Beressi JP; Franc B; Niccoli-Sire P; Conte-Devolx B; Murat A; Caron P; Baldet L; Kraimps JL; Cohen R; Bigorgne JC; Chabre O; Lecomte P; Modigliani E
    Thyroid; 1998 Nov; 8(11):1039-44. PubMed ID: 9848720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different outcomes in sporadic versus familial medullary thyroid cancer.
    Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
    Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for sporadic medullary thyroid carcinoma.
    Gülben K; Berberoğlu U; Boyabatli M
    World J Surg; 2006 Jan; 30(1):84-90. PubMed ID: 16369705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival.
    Hyer SL; Vini L; A'Hern R; Harmer C
    Eur J Surg Oncol; 2000 Nov; 26(7):686-90. PubMed ID: 11187027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
    Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
    Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.